Whole-Body Proteolysis Rate Is Elevated in HIV-Associated Insulin Resistance
16th Nov 2006, 08:08 GMT
These findings point to several potential insulin signaling and metabolic pathways that may be integrated and involved in the pathogenesis of HIV metabolic syndromes. Diabetes
Whole-Body Proteolysis Rate Is Elevated in HIV-Associated Insulin Resistance related news:
- Volume 194, number 12: Treatment Benefit on Cerebrospinal Fluid HIV-1 Levels in the Setting of Systemic Virological Suppression and Failure — J Infect Dis Latest Issue
- Uganda: HIV/Aids Song Released — AllAfrica News: HIV-Aids and STDs
- [Statistics] Genotypic predictors of human immunodeficiency virus type 1 drug resistance — Proceedings of the National Academy of Sciences recent issues
- IIF Aims to Draw Attention to Plight of People With Insulin-Requiring Diabetes on World Diabetes Day 2006 — PR Leap - Recent News Releases
- BMI and waist size predict pre-diabetic state — Reuters: Health
- Nautilus Biotech and Creabilis Therapeutics Achieve Technical Milestone in Collaboration to Improve HMGB1 Box A for the Treatment of Rage- and HMGB1-Related Pathologies. — Radiology News from StratCenter.com
- Ghana: National Agenda to Regulate Sex Work And HIV/Aids in the Offing — AllAfrica News: HIV-Aids and STDs
- Resistance fête sa sortie en images — JEUXFRANCE.COM
- China develops its own pancreatic cell technology for diabetics — People's Daily Online
- Understanding the Scourge of HIV-AIDS in Sub-Saharan Africa — Medscape Hiv-Aids Headlines
Latest news from Medscape Diabetes Headlines:
- Effects of a Lifestyle Modification Program in HIV-Infected Patients with the Metabolic Syndrome
- Lifestyle Intervention Has Lasting Benefits in Those at Risk for Diabetes
- Metabolic Syndrome Is Associated With Greater Histologic Severity, Higher Carbohydrate, and Lower Fat Diet in Patients With NAFLD
- Addition of Basal Insulin to Oral Antidiabetic Agents: A Goal-Directed Approach to Type 2 Diabetes Therapy